Trupanion Inc
$ 24.74
-0.28%
13 Mar - close price
- Market Cap 1,074,462,000 USD
- Current Price $ 24.74
- High / Low $ 25.14 / 24.50
- Stock P/E 54.98
- Book Value 8.85
- EPS 0.45
- Next Earning Report 2026-05-07
- Dividend Per Share N/A
- Dividend Yield 0 %
- Next Dividend Date -
- ROA 0.01 %
- ROE 0.06 %
- 52 Week High 57.88
- 52 Week Low 24.50
About
Trupanion, Inc. offers monthly subscription medical insurance for dogs and cats in the United States, Canada, Puerto Rico and Australia. The company is headquartered in Seattle, Washington.
Analyst Target Price
$46.25
Quarterly Earnings
| Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2026-02-12 | 2025-10-28 | 2025-08-07 | 2025-04-30 | 2025-02-13 | 2024-10-30 | 2024-08-08 | 2024-05-02 | 2024-02-15 | 2023-11-02 | 2023-08-03 | 2023-05-04 |
| Reported EPS | 0.13 | 0.7669 | 0.22 | 0.19 | 0.0391 | 0.03 | -0.14 | -0.16 | -0.05 | -0.1 | -0.33 | -0.6 |
| Estimated EPS | 0.1617 | 0.0196 | -0.04 | -0.2 | 0.84 | -0.06 | -0.18 | -0.2 | -0.18 | -0.31 | -0.41 | -0.29 |
| Surprise | -0.0317 | 0.7473 | 0.26 | 0.39 | -0.8009 | 0.09 | 0.04 | 0.04 | 0.13 | 0.21 | 0.08 | -0.31 |
| Surprise Percentage | -19.6042% | 3812.7551% | 650% | 195% | -95.3452% | 150% | 22.2222% | 20% | 72.2222% | 67.7419% | 19.5122% | -106.8966% |
Next Quarterly Earnings
| Mar 2026 | |
|---|---|
| Reported Date | 2026-05-07 |
| Fiscal Date Ending | 2026-03-31 |
| Estimated EPS | 0.07 |
| Currency | USD |
Next Dividend Records
| Dividend per share (year): | - |
| Dividend Yield | - |
| Next Dividend Date | - |
| Ex-Dividend Date | - |
Recent News: TRUP
2026-03-15 03:52:17
Trupanion (TRUP) recently announced a partnership with the Human Animal Bond Research Institute (HABRI) focusing on veterans and service dogs, which aligns with its mission but is not expected to be a direct financial driver in the short term. The company's main catalyst remains sustaining profitable growth after achieving its first full year of GAAP profitability in 2025 with $19.43 million in net income. While the HABRI partnership is good for brand reputation, investors should also consider the challenges of rising pet acquisition costs and modest new pet additions for Trupanion's future performance.
2026-03-14 00:51:43
Trupanion Inc (TRUP) is projected to report a loss of 3 cents per share and a 10.1% increase in quarterly revenue to $346.673 million when it releases its results for the period ending June 30, 2025. Analysts currently rate the shares as a "buy" with a median 12-month price target of $56.00, suggesting a 15.5% upside from its last closing price. The company's guidance for the quarter included revenue between $344.00 million and $350.00 million and EBIT between USD27 million and USD30 million.
2026-03-13 13:52:17
Trupanion (TRUP) announced a partnership with the Human Animal Bond Research Institute (HABRI) to focus on research and advocacy supporting the human-animal connection. This collaboration aims to use data-driven insights to inform programs benefiting pet and human welfare, potentially deepening Trupanion's ties with various groups and influencing brand perception. For investors, this alliance offers a new dimension to watch beyond traditional metrics, linking Trupanion's brand to research on how pets support human health.
2026-03-13 03:52:55
Trupanion has partnered with the Human Animal Bond Research Institute (HABRI) to focus on research and advocacy supporting the human-animal connection. This collaboration aims to use data-driven insights to inform programs and policies, potentially strengthening Trupanion's brand perception and enhancing its appeal to various groups, including veterans and organizations focused on health. While unlikely to immediately boost revenue, the alliance could foster deeper relationships and differentiate Trupanion in the pet insurance market.
2026-03-11 17:52:16
Trupanion Inc. (TRUP) stock has fallen to a new 52-week low of $25.23, marking a significant 45% decline from its 52-week high and a 22.65% decrease over the past year. Despite this downturn, InvestingPro analysis suggests the stock may be undervalued, with an attractive PEG ratio pointing to potential future upside. The company recently reported mixed Q4 2025 earnings, falling short on EPS but exceeding revenue expectations, and announced a new partnership with the Human Animal Bond Research Institute.
2026-03-11 16:05:00
Trupanion, Inc. (TRUP) stock has fallen to a new 52-week low of $25.11, marking a 10.17% decrease over the past year, contrasting with broader market gains. Despite this decline, the company exhibits strong long-term fundamentals, including an 85.81% CAGR in operating profits and consistent quarterly growth in net sales. High institutional holdings suggest continued investor interest despite recent stock performance challenges.
